Showing results (71-80 of 83) with videos related to
Sort By:
Pageof 9
Journal of Pharmaceutical Policy and Practice|October 31, 2025
Promoting pharmacovigilance through educational strategies: impact of a national training intervention on the knowledge and practice of healthcare providers in JordanNizar Mahmoud Mhaidat, Sayer Al-Azzam, Jaber Mohammad Jaber, et al.The Journal of Antimicrobial Chemotherapy|November 21, 2020
Impact of an antimicrobial stewardship programme on reducing broad-spectrum antibiotic use and its effect on carbapenem-resistant Acinetobacter baumannii (CRAb) in hospitals in JordanDawood Yusef, Wail A Hayajneh, Ali Bani Issa, et al.Medicine|September 25, 2023
Reported long-term effects of COVID-19 patients after hospital discharge in JordanReema Karasneh, Sarah Al Sharie, Sayer Al-Azzam, et al.Clinical Practice and Epidemiology in Mental Health : CP & EMH|June 5, 2023
Trends of Prevalence Estimates and Risk Factors of Depressive Symptoms among Healthcare Workers Over one Year of the COVID-19 PandemicAhmed Yassin, Abdel-Hameed Al-Mistarehi, Ola Soudah, et al.Journal of Clinical Medicine|July 14, 2023
A Jordanian Multidisciplinary Consensus Statement on the Management of DyslipidemiaEyas Al Mousa, Sayer Al-Azzam, Mohammad Araydah, et al.Journal of Pharmaceutical Policy and Practice|January 5, 2021
General practitioner practice-based pharmacist input to medicines optimisation in the UK: pragmatic, multicenter, randomised, controlled trialNadia Farhanah Syafhan, Sayer Al Azzam, Steven D Williams, et al.Healthcare (Basel, Switzerland)|February 25, 2023
The Impact of Multidrug-Resistant Acinetobacter baumannii Infection in Critically Ill Patients with or without COVID-19 InfectionThamer A Alenazi, Maryam S Bin Shaman, Durria M Suliman, et al.British Journal of Clinical Pharmacology|May 10, 2023
The impact of the COVID-19 pandemic on antibiotic consumption and prevalence of pathogens in primary and secondary healthcare settings in Northern IrelandMamoon A Aldeyab, William Crowe, Reema A Karasneh, et al.Cureus|September 24, 2024
Enhanced Treatment in Severe-Critical COVID-19 With Tocilizumab, Remdesivir, Dexamethasone: A Jordanian Cohort StudyAbdel-Hameed W Al-Mistarehi, Shadi El-Akawi, Khalid A Kheirallah, et al.Vaccines|October 28, 2023
Lessons Learned from the Pandemic in the UAE: Children COVID-19 Vaccine Hesitancy and Its Impact on the Choice of Distance versus Face-to-Face Learning Modalities: An In-Depth Analysis of a National StudyZelal Kharaba, Yassen Alfoteih, Karem H Alzoubi, et al.Pageof 9